← Eichor
Condition: Hereditary Breast And Ovarian Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hereditary Breast And Ovarian Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ov
Phase N/A · 1 location(s) · Peking University Third Hospital · NCT07532434
Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation
Phase N/A · 1 location(s) · Institut Paoli-Calmettes · NCT03667417
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT03702309
Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Probands
Phase N/A · 1 location(s) · Peking University Third Hospital · NCT07039552
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Phase N/A · 11 location(s) · University of Kansas Medical Center · NCT02302742
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Phase N/A · 1 location(s) · Northwestern University · NCT00005095
Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268
Pancreatic Cancer Genetics
Phase N/A · 1 location(s) · Columbia University · NCT01102569
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Parti
Phase 1/Phase 2 · 65 location(s) · Eli Lilly and Company · NCT05768139
Identifying and Caring for Individuals With Inherited Cancer Syndrome
NA · 2 location(s) · OHSU Knight Cancer Institute · NCT04494945
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
NA · 1 location(s) · Peking University First Hospital · NCT07557225
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
NA · 1 location(s) · Georgetown University · NCT06892275
Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland
Phase N/A · 9 location(s) · University of Basel · NCT03124212
Integrated Cancer Repository for Cancer Research
Phase N/A · 42 location(s) · University of Nebraska · NCT02012699
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Phase 1/Phase 2 · 15 location(s) · Ensem Therapeutics · NCT06993844
CfDNA in Hereditary And High-risk Malignancies 2
Phase N/A · 8 location(s) · University Health Network, Toronto · NCT06726642
COsegregation of VARiants in Panel of Genes
NA · 62 location(s) · Institut Curie · NCT01689584
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
NA · 4 location(s) · Memorial Sloan Kettering Cancer Center · NCT04751435
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Phase N/A · 1 location(s) · MiraKind · NCT02253251
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
NA · 2 location(s) · Georgetown University · NCT05130606
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT05649072
Population Based Germline Testing for Early Detection and Prevention of Cancer
NA · 1 location(s) · Queen Mary University of London · NCT07498829
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.